Pandect Bioventures collects $33m for $100m-targeted fund

Pandect Bioventures has raised $33 million for its new fund, according to an SEC filing.

To read this article, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to read this article and more for free.

Share this